$CNMD
CONMED Corp

2013 Q2 Form 10-Q Financial Statement

#000081695613000008 Filed on July 29, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $193.0M $189.7M
YoY Change 1.74% 3.52%
Cost Of Revenue $90.08M $89.96M
YoY Change 0.13% -1.98%
Gross Profit $102.9M $99.73M
YoY Change 3.19% 9.05%
Gross Profit Margin 53.33% 52.57%
Selling, General & Admin $77.17M $73.71M
YoY Change 4.7% 8.61%
% of Gross Profit 74.99% 73.91%
Research & Development $6.591M $7.192M
YoY Change -8.36% 5.81%
% of Gross Profit 6.4% 7.21%
Depreciation & Amortization $12.10M $11.30M
YoY Change 7.08% 16.49%
% of Gross Profit 11.76% 11.33%
Operating Expenses $87.26M $82.67M
YoY Change 5.55% 10.59%
Operating Profit $15.65M $17.06M
YoY Change -8.24% 2.16%
Interest Expense $1.383M $1.551M
YoY Change -10.83% -9.14%
% of Operating Profit 8.84% 9.09%
Other Income/Expense, Net
YoY Change
Pretax Income $14.27M $15.51M
YoY Change -7.98% 11.74%
Income Tax $4.736M $5.211M
% Of Pretax Income 33.19% 33.6%
Net Earnings $9.533M $10.30M
YoY Change -7.41% 18.62%
Net Earnings / Revenue 4.94% 5.43%
Basic Earnings Per Share $0.35 $0.36
Diluted Earnings Per Share $0.34 $0.36
COMMON SHARES
Basic Shares Outstanding 27.59M shares 28.33M shares
Diluted Shares Outstanding 27.98M shares 28.67M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.10M $16.20M
YoY Change 135.19% -33.33%
Cash & Equivalents $38.12M $16.25M
Short-Term Investments
Other Short-Term Assets $28.40M $25.90M
YoY Change 9.65% 18.26%
Inventory $148.7M $159.2M
Prepaid Expenses
Receivables $140.6M $136.1M
Other Receivables $2.800M $0.00
Total Short-Term Assets $358.6M $337.4M
YoY Change 6.27% -8.36%
LONG-TERM ASSETS
Property, Plant & Equipment $137.6M $140.8M
YoY Change -2.29% 0.03%
Goodwill $249.2M $234.8M
YoY Change 6.1%
Intangibles $186.8M $191.7M
YoY Change -2.56%
Long-Term Investments
YoY Change
Other Assets $150.8M $156.4M
YoY Change -3.58% 1563.83%
Total Long-Term Assets $724.4M $723.8M
YoY Change 0.09% 14.52%
TOTAL ASSETS
Total Short-Term Assets $358.6M $337.4M
Total Long-Term Assets $724.4M $723.8M
Total Assets $1.083B $1.061B
YoY Change 2.05% 6.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.22M $29.06M
YoY Change -6.31% 38.37%
Accrued Expenses $25.90M $24.40M
YoY Change 6.15% 5.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.093M $22.53M
YoY Change -95.15% -84.36%
Total Short-Term Liabilities $99.16M $135.2M
YoY Change -26.69% -35.69%
LONG-TERM LIABILITIES
Long-Term Debt $233.0M $145.4M
YoY Change 60.22% 375.28%
Other Long-Term Liabilities $60.55M $87.75M
YoY Change -30.99% 215.64%
Total Long-Term Liabilities $293.6M $233.2M
YoY Change 25.9% 299.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $99.16M $135.2M
Total Long-Term Liabilities $293.6M $233.2M
Total Liabilities $498.4M $467.8M
YoY Change 6.52% 21.99%
SHAREHOLDERS EQUITY
Retained Earnings $389.6M $366.2M
YoY Change 6.39%
Common Stock $313.0K $313.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $99.21M $66.53M
YoY Change 49.12%
Treasury Stock Shares
Shareholders Equity $584.7M $593.4M
YoY Change
Total Liabilities & Shareholders Equity $1.083B $1.061B
YoY Change 2.05% 6.1%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $9.533M $10.30M
YoY Change -7.41% 18.62%
Depreciation, Depletion And Amortization $12.10M $11.30M
YoY Change 7.08% 16.49%
Cash From Operating Activities $17.70M $25.70M
YoY Change -31.13% 31.79%
INVESTING ACTIVITIES
Capital Expenditures -$4.100M -$5.200M
YoY Change -21.15% 15.56%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$4.100M -$5.200M
YoY Change -21.15% 18.18%
FINANCING ACTIVITIES
Cash Dividend Paid $4.300M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.800M -22.90M
YoY Change -70.31% 151.65%
NET CHANGE
Cash From Operating Activities 17.70M 25.70M
Cash From Investing Activities -4.100M -5.200M
Cash From Financing Activities -6.800M -22.90M
Net Change In Cash 6.800M -2.400M
YoY Change -383.33% -140.0%
FREE CASH FLOW
Cash From Operating Activities $17.70M $25.70M
Capital Expenditures -$4.100M -$5.200M
Free Cash Flow $21.80M $30.90M
YoY Change -29.45% 28.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
27223000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23622000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139124000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
140570000 USD
CY2013Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1617000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2706000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27581000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28852000 USD
CY2013Q2 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P29Y
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
324322000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
322792000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
13790000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14648000 USD
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1930000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2021000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3862000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4009000 USD
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2013Q2 us-gaap Assets
Assets
1083020000 USD
CY2012Q4 us-gaap Assets
Assets
1079507000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
358606000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
348893000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23720000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38123000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16246000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26048000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9802000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14403000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2012Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2013Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31299194 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31299194 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
313000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
313000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7380000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18754000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18732000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7687000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7380000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
18754000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
18732000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7687000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
183368000 USD
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
89963000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90077000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
174409000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6091000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5038000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
11931000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
10548000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
138000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
130000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1166000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1057000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
99857000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
105630000 USD
CY2013Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-732000 USD
CY2012Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-731000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-1463000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-1463000 USD
CY2013Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
7500000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2262000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2604000 USD
CY2013Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1302000 USD
CY2012Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1131000 USD
CY2012Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
860000 USD
CY2013Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
785000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1719000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1571000 USD
CY2013Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
284000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
568000 USD
CY2012Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
525000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1050000 USD
CY2013Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
69000 USD
CY2012Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
65000 USD
us-gaap Depreciation
Depreciation
9168000 USD
us-gaap Depreciation
Depreciation
9274000 USD
CY2012Q4 us-gaap Derivative Assets
DerivativeAssets
457000 USD
CY2013Q2 us-gaap Derivative Assets
DerivativeAssets
2574000 USD
CY2012Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-1942000 USD
CY2013Q2 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
2111000 USD
CY2012Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2399000 USD
CY2013Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
463000 USD
CY2012Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4262000 USD
CY2013Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4123000 USD
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-294000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2689000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1027000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1365000 USD
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25885000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33511000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87637000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
91646000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7240000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7866000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
6682000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
6737000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6751000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6860000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-200000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-300000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1600000 USD
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-700000 USD
CY2013Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2012Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-263000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2013Q2 us-gaap Goodwill
Goodwill
249160000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
249160000 USD
CY2013Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-7661000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
102916000 USD
us-gaap Gross Profit
GrossProfit
205598000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
99732000 USD
us-gaap Gross Profit
GrossProfit
200643000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
31092000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14269000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
28510000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15507000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10828000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8485000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4736000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5211000 USD
CY2013Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2800000 USD
CY2012Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2897000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2207000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1345000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1171000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4589000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7393000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-6730000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3078000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1581000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-3129000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-13013000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3714000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1779000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-9014000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-9729000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
190809000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
186823000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
1383000 USD
us-gaap Interest Expense
InterestExpense
2988000 USD
us-gaap Interest Expense
InterestExpense
2749000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
1551000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
96884000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
88578000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
156228000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
148717000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
45115000 USD
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
45665000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14474000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14229000 USD
us-gaap Legal Fees
LegalFees
1555000 USD
CY2012Q2 us-gaap Legal Fees
LegalFees
544000 USD
CY2013Q2 us-gaap Legal Fees
LegalFees
527000 USD
us-gaap Legal Fees
LegalFees
736000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
472509000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
498353000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1083020000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1079507000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
99155000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
125214000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1093000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1814000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2127000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
233017000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
160802000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1050000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring.&#160;&#160;The Company&#8217;s products are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32927000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
815000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8201000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75712000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23154000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33277000 USD
us-gaap Operating Expenses
OperatingExpenses
166563000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
82674000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
87264000 USD
us-gaap Operating Expenses
OperatingExpenses
174076000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
34080000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
31522000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
17058000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15652000 USD
CY2012Q4 us-gaap Other Assets
OtherAssets
150547000 USD
CY2013Q2 us-gaap Other Assets
OtherAssets
149653000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
379000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
292000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
2506000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1269000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2993000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4699000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1186000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3362000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-923000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-922000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-461000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-461000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3763000 USD
CY2012Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1775000 USD
CY2013Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2093000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3906000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
64325000 USD
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
43337000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
86636000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
60551000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
44729000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
-2747000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1725000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4328000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8445000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11596000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8201000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17848000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14993000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
73000000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
57000000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10366000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7868000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7090000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
4925000 USD
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3272000 USD
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3702000 USD
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3618000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3636000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2178000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2043000 USD
us-gaap Profit Loss
ProfitLoss
20264000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
9533000 USD
us-gaap Profit Loss
ProfitLoss
20025000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
10296000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
137612000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
139041000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
227000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
515000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
475000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
32063000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7192000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12285000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6591000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14287000 USD
us-gaap Restructuring Charges
RestructuringCharges
2126000 USD
CY2013Q2 us-gaap Restructuring Reserve
RestructuringReserve
3499000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
4120000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
377907000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
389620000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
192993000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
189695000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
380007000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
384011000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
148513000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
154899000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73707000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77174000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2496000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2574000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
606998000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
584667000 USD
CY2013Q2 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
3813051 shares
CY2012Q4 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
2925801 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
67963000 USD
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
99206000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
398000 shares
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
345000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
399000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
392000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28258000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28577000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27983000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28672000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27860000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28178000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27591000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28327000 shares
CY2013Q2 cnmd Excise Tax Medical
ExciseTaxMedical
1406000 USD
cnmd Excise Tax Medical
ExciseTaxMedical
0 USD
CY2012Q2 cnmd Excise Tax Medical
ExciseTaxMedical
0 USD
cnmd Excise Tax Medical
ExciseTaxMedical
2986000 USD
CY2012Q4 cnmd Goodwill As Reported
GoodwillAsReported
256821000 USD
CY2012Q4 cnmd Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
278446000 USD
CY2013Q2 cnmd Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
278469000 USD
CY2013Q2 cnmd Joint Development And Distribution Agreement Accumulated Amortization
JointDevelopmentAndDistributionAgreementAccumulatedAmortization
9000000 USD
CY2012Q1 cnmd Joint Development And Distribution Agreement Conditional Payment Amount
JointDevelopmentAndDistributionAgreementConditionalPaymentAmount
84000000 USD
CY2013Q2 cnmd Joint Development And Distribution Agreement Conditional Payment Amount Accrued
JointDevelopmentAndDistributionAgreementConditionalPaymentAmountAccrued
50000000 USD
CY2012Q1 cnmd Joint Development And Distribution Agreement Conditional Payment Period
JointDevelopmentAndDistributionAgreementConditionalPaymentPeriod
P4Y
CY2013Q2 cnmd Joint Development And Distribution Agreement Gross Carrying Amount
JointDevelopmentAndDistributionAgreementGrossCarryingAmount
149400000 USD
CY2012Q1 cnmd Joint Development And Distribution Agreement Up Front Payment
JointDevelopmentAndDistributionAgreementUpFrontPayment
63000000 USD
cnmd Payments For Contingent Payments
PaymentsForContingentPayments
34000000 USD
cnmd Payments For Contingent Payments
PaymentsForContingentPayments
0 USD
cnmd Payments Related To Distribution Agreement
PaymentsRelatedToDistributionAgreement
0 USD
cnmd Payments Related To Distribution Agreement
PaymentsRelatedToDistributionAgreement
64116000 USD
CY2013Q2 cnmd Product Liability Contingency Insurance Aggregate Annual Amount
ProductLiabilityContingencyInsuranceAggregateAnnualAmount
25000000 USD
CY2013Q2 cnmd Product Liability Contingency Insurance Amount Per Incident
ProductLiabilityContingencyInsuranceAmountPerIncident
25000000 USD
cnmd Product Warranty Accrual Term
ProductWarrantyAccrualTerm
P1Y
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000816956
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27490288 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CONMED CORP

Files In Submission

Name View Source Status
0000816956-13-000008-index-headers.html Edgar Link pending
0000816956-13-000008-index.html Edgar Link pending
0000816956-13-000008.txt Edgar Link pending
0000816956-13-000008-xbrl.zip Edgar Link pending
cnmd-20130630.xml Edgar Link completed
cnmd-20130630.xsd Edgar Link pending
cnmd-20130630_cal.xml Edgar Link unprocessable
cnmd-20130630_def.xml Edgar Link unprocessable
cnmd-20130630_lab.xml Edgar Link unprocessable
cnmd-20130630_pre.xml Edgar Link unprocessable
cnmd6301310-q.htm Edgar Link pending
cnmd63013ex311.htm Edgar Link pending
cnmd63013ex312.htm Edgar Link pending
cnmd63013ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending